Shares of Novartis were climbing higher on Friday after the Food and Drug Administration (FDA) approved Novartis’ $2.1 million gene therapy Zolgensma. Zolgensma is a one-time treatment for spinal muscular atrophy and is the world’s most expensive drug now. Previously Novartis had said that the treatment could cost anywhere from $1.5 to $5 million but … Continue reading “Novartis’ Gene Therapy Gets Nod from FDA”
Tag: nvs
Biotech & Pharma
Novartis is Buying Endocyte for $2.1 Billion
Pharmaceutical giant Novartis is making a big purchase. The Swiss company is purchasing U.S. Endocyte…
October 18, 2018
Hot Stocks
AT&T CEO Says it Was Mistake to Hire Trump’s Lawyer
AT&T Inc.'s CEO Randall Stephenson is regretting that it hired Michael Cohen, President Donald Trump's…
May 11, 2018
Biotech & Pharma
Novartis Just Made an $8.7 Billion Dollar Bet on this Gene Therapy Company
Novartis and AveXis shares saw big gains in Monday trading after it was announced that…
April 9, 2018
Biotech & Pharma
Novartis to Buy This Big French Drug Maker for $3.9 Billion
Novartis AG announced on Monday that it will be acquiring Advanced Accelerator Applications, a French…
October 30, 2017
Biotech & Pharma
Novartis Climbs Higher After Earnings Rise
Shares of Swiss pharmaceuticals company Novartis saw its share price climb higher on Tuesday after…
October 24, 2017
Biotech & Pharma
Novartis AG CEO Resigns Suddenly
The CEO of Novarti AG has suddenly resigned. Chief Executive Officer Joseph Jimenez has been…
September 4, 2017